JP MORGAN/CALL/ELI LILLY & CO/920/0.1/21.06.24 Share Price

Warrant

DE000JB4NTX4

Market Closed - Börse Stuttgart 01:11:35 14/06/2024 pm IST
0.3 EUR +36.36% Intraday chart for JP MORGAN/CALL/ELI LILLY & CO/920/0.1/21.06.24
Current month+66.67%
1 month+289.61%
Date Price Change
14/24/14 0.3 +36.36%
13/24/13 0.22 -21.43%
12/24/12 0.28 +27.27%
11/24/11 0.22 -12.00%
10/24/10 0.25 +92.31%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 01:11 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer J.P. Morgan
WKN JB4NTX
ISINDE000JB4NTX4
Date issued 18/10/2023
Strike 920 $
Maturity 21/06/2024 (6 Days)
Parity 10 : 1
Emission price 0.79
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.16
Lowest since issue 0.075

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus